Form 4: Intra-Cellular Therapies Executive Halstead Reports Stock Transactions
SEC Form 4 Filing
Michael Halstead, President of Intra-Cellular Therapies, reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Summary
- On March 6, 2025, Michael Halstead, President of Intra-Cellular Therapies, exercised 13,133 restricted stock units which converted into common stock.
- The company withheld 6,718 shares to cover tax obligations at a price of $131.19 per share.
- Following these transactions, Halstead directly owns 17,719 shares of common stock.
- On March 10, 2025, Halstead exercised 7,345 restricted stock units which converted into common stock.
- The company withheld 3,757 shares to cover tax obligations at a price of $131.24 per share.
- Following these transactions, Halstead directly owns 21,307 shares of common stock.
Sentiment
Score: 5
Explanation: This is a neutral filing related to standard executive compensation practices; it doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common occurrence in publicly traded companies.
Stakeholder Impact
- The transactions have a minor dilutive effect on existing shareholders due to the issuance of new shares upon vesting of restricted stock units.
Key Dates
| Date | Description |
|---|---|
| March 10, 2022 | Reporting person was granted 22,034 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |
| March 6, 2023 | Reporting person was granted 39,398 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |
| March 6, 2025 | Halstead exercised 13,133 restricted stock units and the company withheld 6,718 shares for taxes. |
| March 10, 2025 | Halstead exercised 7,345 restricted stock units and the company withheld 3,757 shares for taxes. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.